{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:46:55Z","timestamp":1792180015717,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.tem.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T14:01:48Z","timestamp":1443103308000},"page":"538-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":599,"title":["Ceramides \u2013 Lipotoxic Inducers of Metabolic Disorders"],"prefix":"10.1016","volume":"26","author":[{"given":"Bhagirath","family":"Chaurasia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2015.07.006_bib0600","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2337\/diab.44.8.863","article-title":"Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications","volume":"44","author":"Unger","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0715","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","article-title":"Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte\u2013beta-cell relationships","volume":"91","author":"Lee","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2015.07.006_bib0720","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2015.07.006_bib0725","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0730","doi-asserted-by":"crossref","first-page":"32487","DOI":"10.1074\/jbc.273.49.32487","article-title":"Lipoapoptosis in beta-cells of obese prediabetic fa\/fa rats. Role of serine palmitoyltransferase overexpression","volume":"273","author":"Shimabukuro","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0735","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0740","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0745","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2007.09.018","article-title":"Ceramide: a common pathway for atherosclerosis?","volume":"196","author":"Bismuth","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tem.2015.07.006_bib0750","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramide-centric view of insulin resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0755","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1074\/jbc.M112.359950","article-title":"Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis","volume":"287","author":"Bikman","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0760","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib0765","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1172\/JCI57144","article-title":"Ceramides as modulators of cellular and whole-body metabolism","volume":"121","author":"Bikman","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib0770","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOL.0b013e3283373b66","article-title":"Sphingolipids and insulin resistance: the five Ws","volume":"21","author":"Summers","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.tem.2015.07.006_bib0775","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS\u2013Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0780","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1074\/jbc.M412348200","article-title":"Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice","volume":"280","author":"Hojjati","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0785","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","author":"Park","year":"2012","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.tem.2015.07.006_bib0790","doi-asserted-by":"crossref","first-page":"18429","DOI":"10.1074\/jbc.M111.296947","article-title":"Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0795","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4614-0650-1_2","article-title":"Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy","volume":"721","author":"Jiang","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib0800","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2015.07.006_bib0805","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/978-1-4419-6741-1_6","article-title":"Ceramide in stress response","volume":"688","author":"Nikolova-Karakashian","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib0810","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molmed.2007.06.002","article-title":"Translational aspects of sphingolipid metabolism","volume":"13","author":"Zeidan","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0815","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbalip.2009.01.006","article-title":"CERT-mediated trafficking of ceramide","volume":"1791","author":"Hanada","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2015.07.006_bib0820","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.2174\/092986709788682182","article-title":"Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate","volume":"16","author":"Claus","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0825","doi-asserted-by":"crossref","first-page":"12972","DOI":"10.1074\/jbc.M802790200","article-title":"Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation","volume":"284","author":"Kitatani","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","article-title":"Ceramide content is increased in skeletal muscle from obese insulin-resistant humans","volume":"53","author":"Adams","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0605","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/db10-1221","article-title":"Skeletal-muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?","volume":"60","author":"Amati","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0835","doi-asserted-by":"crossref","first-page":"E882","DOI":"10.1152\/ajpendo.00769.2007","article-title":"Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited","volume":"294","author":"Dube","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0840","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00125-011-2065-0","article-title":"Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide","volume":"54","author":"Dube","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2015.07.006_bib0845","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1007\/s00125-009-1482-9","article-title":"Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease","volume":"52","author":"de Mello","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2015.07.006_bib0850","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0855","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ijo.2012.191","article-title":"Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet","volume":"37","author":"Brozinick","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.tem.2015.07.006_bib0860","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1073\/pnas.1311176110","article-title":"Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo","volume":"110","author":"Galbo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2015.07.006_bib0865","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.2337\/db12-1179","article-title":"Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans","volume":"62","author":"Nowotny","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0870","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2003.08.020","article-title":"Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes","volume":"419","author":"Chavez","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tem.2015.07.006_bib0875","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1194\/jlr.M800635-JLR200","article-title":"Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity","volume":"50","author":"Hu","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2015.07.006_bib0880","doi-asserted-by":"crossref","first-page":"16596","DOI":"10.1074\/jbc.M110.186916","article-title":"Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance","volume":"286","author":"Hu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0885","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib0890","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tem.2015.07.006_bib0895","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-011-9589-4","article-title":"Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome","volume":"41","author":"Majumdar","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2015.07.006_bib0900","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib0905","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0910","doi-asserted-by":"crossref","first-page":"38568","DOI":"10.1074\/jbc.M110.170621","article-title":"Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy","volume":"285","author":"Sims","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0915","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1074\/jbc.M112.419978","article-title":"Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages","volume":"288","author":"Schilling","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0920","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/imr.12295","article-title":"Drivers of age-related inflammation and strategies for healthspan extension","volume":"265","author":"Goldberg","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tem.2015.07.006_bib0925","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0930","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1210\/en.2011-1326","article-title":"Elimination of the NLRP3\u2013ASC inflammasome protects against chronic obesity-induced pancreatic damage","volume":"152","author":"Youm","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2015.07.006_bib0935","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2015.07.006_bib0940","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1172\/JCI31021","article-title":"Obesity-associated improvements in metabolic profile through expansion of adipose tissue","volume":"117","author":"Kim","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","article-title":"AMPK: positive and negative regulation, and its role in whole-body energy homeostasis","volume":"33","author":"Hardie","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib0950","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/mol.109.054817","article-title":"PAQRs: a counteracting force to ceramides?","volume":"75","author":"Holland","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tem.2015.07.006_bib0955","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0960","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tem.2010.11.003","article-title":"FGF21 reloaded: challenges of a rapidly growing field","volume":"22","author":"Kharitonenkov","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0965","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21\u2013adiponectin\u2013ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0970","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2015.07.006_bib0610","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib0975","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbalip.2009.09.015","article-title":"Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms","volume":"1801","author":"Chavez","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2015.07.006_bib0980","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/MCB.18.9.5457","article-title":"Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide","volume":"18","author":"Summers","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib0985","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.1074\/jbc.M406499200","article-title":"Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B","volume":"279","author":"Stratford","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0990","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1128\/MCB.23.21.7794-7808.2003","article-title":"Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)\/Akt by a PKCzeta-dependent mechanism","volume":"23","author":"Powell","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib0995","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/BJ20070936","article-title":"Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide","volume":"410","author":"Hajduch","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2015.07.006_bib1000","doi-asserted-by":"crossref","first-page":"20148","DOI":"10.1074\/jbc.M412769200","article-title":"Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling","volume":"280","author":"Chavez","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib1005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/BJ20081149","article-title":"Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells","volume":"417","author":"Watson","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2015.07.006_bib1010","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1152\/ajpendo.91014.2008","article-title":"Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome","volume":"297","author":"Yang","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib1015","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/db09-1293","article-title":"Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption","volume":"59","author":"Ussher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0615","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1113\/EP085052","article-title":"Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat","volume":"100","author":"Fillmore","year":"2015","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.tem.2015.07.006_bib0620","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2013.01.041","article-title":"Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction","volume":"228","author":"Dekker","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tem.2015.07.006_bib0625","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0630","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1128\/MCB.05893-11","article-title":"Reducing plasma membrane sphingomyelin increases insulin sensitivity","volume":"31","author":"Li","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib0635","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2337\/db12-0686","article-title":"Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance","volume":"62","author":"Boon","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0640","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1074\/jbc.M103705200","article-title":"Ganglioside GM3 participates in the pathological conditions of insulin resistance","volume":"277","author":"Tagami","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0645","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","article-title":"Enhanced insulin sensitivity in mice lacking ganglioside GM3","volume":"100","author":"Yamashita","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2015.07.006_bib0650","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1476-511X-9-113","article-title":"Sphingolipids: the nexus between Gaucher disease and insulin resistance","volume":"9","author":"Fuller","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.tem.2015.07.006_bib0655","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1210\/jc.2007-1702","article-title":"Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance","volume":"93","author":"Langeveld","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0660","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"Aerts","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib0665","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.23175","article-title":"Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice","volume":"50","author":"Bijl","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2015.07.006_bib0670","doi-asserted-by":"crossref","first-page":"e4723","DOI":"10.1371\/journal.pone.0004723","article-title":"Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation","volume":"4","author":"van Eijk","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2015.07.006_bib0675","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1074\/jbc.M113.522847","article-title":"Ceramides and glucosylceramides are independent antagonists of insulin signaling","volume":"289","author":"Chavez","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib0680","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3949\/ccjm.75.10.721","article-title":"Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome","volume":"75","author":"Kim","year":"2008","journal-title":"Cleveland Clin. J. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib0685","doi-asserted-by":"crossref","first-page":"G959","DOI":"10.1152\/ajpgi.00395.2013","article-title":"Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice","volume":"306","author":"Correnti","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tem.2015.07.006_bib0690","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.12331","article-title":"Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease","volume":"34","author":"Kurek","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.tem.2015.07.006_bib0695","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0700","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cmet.2014.10.017","article-title":"C16:0-ceramide signals insulin resistance","volume":"20","author":"Hla","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib0705","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1021\/bi9924415","article-title":"Ceramide interaction with the respiratory chain of heart mitochondria","volume":"39","author":"Di Paola","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.tem.2015.07.006_bib0710","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation reveals roles for cermaides in non alcoholic fatty liver disease and glucose metabolism in mice","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib1020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2015.07.019","article-title":"The ART of lowering ceramides","volume":"22","author":"Summers","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib1025","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1210\/en.2003-0410","article-title":"Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death","volume":"144","author":"El-Assaad","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2015.07.006_bib1030","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1517\/14728222.2011.588209","article-title":"Ceramide formation as a target in beta-cell survival and function","volume":"15","author":"Lang","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.tem.2015.07.006_bib1035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/BJ20101867","article-title":"A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking","volume":"435","author":"Boslem","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2015.07.006_bib1040","doi-asserted-by":"crossref","first-page":"30015","DOI":"10.1074\/jbc.M302548200","article-title":"Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis","volume":"278","author":"Kelpe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib1045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11010-009-0362-4","article-title":"Blockage of ceramide metabolism exacerbates palmitate inhibition of pro-insulin gene expression in pancreatic beta-cells","volume":"338","author":"Guo","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tem.2015.07.006_bib1050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/diabetes.54.3.591","article-title":"A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome","volume":"54","author":"Summers","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib1055","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1161\/01.CIR.0000148370.60535.22","article-title":"Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice","volume":"110","author":"Park","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2015.07.006_bib1060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","article-title":"Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice","volume":"58","author":"Park","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tem.2015.07.006_bib1065","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1194\/jlr.M600040-JLR200","article-title":"Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice","volume":"47","author":"Dong","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2015.07.006_bib1070","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","article-title":"Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib1075","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1194\/jlr.E800005-JLR200","article-title":"Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice","volume":"49","author":"Glaros","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2015.07.006_bib1080","doi-asserted-by":"crossref","first-page":"e0126910","DOI":"10.1371\/journal.pone.0126910","article-title":"Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis","volume":"10","author":"Kasumov","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2015.07.006_bib1085","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1021\/la800714w","article-title":"Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein","volume":"24","author":"Walters","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.tem.2015.07.006_bib1090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcis.2011.07.072","article-title":"Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation","volume":"363","author":"Walters","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.tem.2015.07.006_bib1095","doi-asserted-by":"crossref","first-page":"823071","DOI":"10.1155\/2014\/823071","article-title":"Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall","volume":"2014","author":"Li","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.tem.2015.07.006_bib1100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.freeradbiomed.2012.05.026","article-title":"Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis","volume":"53","author":"Gao","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib1105","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1074\/jbc.M608310200","article-title":"Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase","volume":"282","author":"Wu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib1110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0009-3084(99)00059-6","article-title":"Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes","volume":"101","author":"Kronke","year":"1999","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.tem.2015.07.006_bib1115","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0022-2275(20)39142-2","article-title":"Effects of sphingomyelinase and sphingosine on arterial vasomotor regulation","volume":"37","author":"Murohara","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2015.07.006_bib1120","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/sj.bjp.0703516","article-title":"Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner","volume":"130","author":"Bischoff","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2015.07.006_bib1125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.CIR.0000080324.12530.0D","article-title":"Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA\/Rho kinase","volume":"108","author":"Bolz","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2015.07.006_bib1130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","article-title":"Lipid metabolism and toxicity in the heart","volume":"15","author":"Goldberg","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2015.07.006_bib1135","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib1140","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/gfq633","article-title":"Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin","volume":"26","author":"Liu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tem.2015.07.006_bib1145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.ki.5000057","article-title":"Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury","volume":"69","author":"Itoh","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2015.07.006_bib1150","doi-asserted-by":"crossref","first-page":"F308","DOI":"10.1152\/ajprenal.00204.2004","article-title":"Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation","volume":"288","author":"Basnakian","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tem.2015.07.006_bib1155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0891-5849(02)00879-1","article-title":"Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol\/ceramide production and oxidative stress induction","volume":"33","author":"Denis","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tem.2015.07.006_bib1160","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/diabetes.54.6.1838","article-title":"Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide","volume":"54","author":"Cacicedo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2015.07.006_bib1165","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1074\/jbc.M807800200","article-title":"Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice","volume":"284","author":"Deevska","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2015.07.006_bib1170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1752-0509-1-12","article-title":"Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis","volume":"1","author":"Yetukuri","year":"2007","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.tem.2015.07.006_bib1175","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI36714","article-title":"Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents","volume":"119","author":"Benoit","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2015.07.006_bib1180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.celrep.2014.08.057","article-title":"Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance","volume":"9","author":"Contreras","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2015.07.006_bib1185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diabres.2011.03.017","article-title":"Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats","volume":"93","author":"Chun","year":"2011","journal-title":"Diab. Res. Clin. Pract."},{"key":"10.1016\/j.tem.2015.07.006_bib1190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-5793(95)00470-T","article-title":"Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta","volume":"367","author":"Sjoholm","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tem.2015.07.006_bib1195","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1074\/jbc.R115.653204","article-title":"Dihydroceramides: from bit players to lead actors","volume":"290","author":"Siddique","year":"2015","journal-title":"J. Biol. Chem."}],"updated-by":[{"DOI":"10.1016\/j.tem.2017.09.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000}}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276015001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276015001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:37:26Z","timestamp":1760906246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276015001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":120,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1043276015001393"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2015.07.006","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceramides \u2013 Lipotoxic Inducers of Metabolic Disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}